Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01847040 · ClinicalTrials.gov registry record

Deployment Related Mild Traumatic Brain Injury (mTBI)

A clinical trial of Mild Traumatic Brain Injury, sponsored by The Defense and Veterans Brain Injury Center.

Completed
Registry status
750
Enrollment target
2
Study locations

NCT01847040: Completed study of Mild Traumatic Brain Injury, sponsored by The Defense and Veterans Brain Injury Center.

NCT01847040 is a study of Mild Traumatic Brain Injury that has completed, run by The Defense and Veterans Brain Injury Center. The registered enrollment target is 750 participants, above the 203-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (269% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01847040, a study of Mild Traumatic Brain Injury, has completed, sponsored by The Defense and Veterans Brain Injury Center.

COMPLETED
Registry status
750 participants
Enrollment target
2
Study locations

Study Summary

The study will provide evidence on the long term outcomes of mTBI in service members returning from Afghanistan and Iraq. In addition, the study will provide evidence on mTBI incidence, and symptom patterns. Self-reported assessments at baseline and follow-ups will be combined with data on health care utilization and military job performance. The work, symptoms, and family interaction outcomes of returning soldiers screening positive for mTBI, combined mTBI and PTSD, and soldier controls will be compared at 3 months, 6 months, and at one year. The assessments over time will permit descriptions of symptom changes for these populations. It is likely the study will find similar findings to those of previous civilian studies - that concussive symptoms often resolve within months of injury. However, some soldier subsets may have chronic problems. Determining the incidence and outcomes of individuals with mTBI will assist medical providers in determining the types of follow-ups needed by returning service members and suggest the development of additional treatment interventions. These results may also inform treatment of civilian populations with mTBI. The three primary hypotheses are: 1. Concussive symptoms at the time of return from serving in Afghanistan and Iraq and symptoms persisting 3 months, 6 months, and 12 months after return will be associated with extent of exposure to combat, injury mechanism, associated injuries (co-occuring injuries), PTSD and other psychiatric co-morbidities, and number of deployment-related mTBIs. 2. Returning troops reporting concussive symptoms at the time of return from deployment will have more work related problems at each follow-up (including lower rates of return to duty, return to work, and poor quality of work). 3. The mTBI screening tool will be sensitive and specific to mTBI when compared to the criterion measure, which is a structured interview conducted by clinicians blinded to the screening results.

Primary Outcome

Concussive symptoms are measured with 3 instruments: Neurobehavioral Symptom Inventory; Patient Health Questionnaire; Headache Questionnaire.

Study Locations (2)

Colorado

  • Fort Carson - Fort Carson

North Carolina

  • Fort Bragg - Fort Bragg

Trial Details

FieldValue
Enrollment Target 750 participants
Start Date 2009-09
Est. Completion 2014-08

What the finished NCT01847040 record still lists

NCT01847040 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, above the 203-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (269% higher).

The record links to 1 condition, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.

NCT01847040 reports a single indexed study location in Colorado, North Carolina.

Frequently Asked Questions

What is clinical trial NCT01847040 about?

NCT01847040 is a clinical study titled "Deployment Related Mild Traumatic Brain Injury (mTBI)". The study will provide evidence on the long term outcomes of mTBI in service members returning from Afghanistan and Iraq. In addition, the study will provide evidence on mTBI incidence, and symptom patterns. Self-reported assessments at baseline and follow-ups will be combined with data on health ca...

What is the current status of trial NCT01847040?

This trial is currently completed. The enrollment target is 750 participants. The study started on 2009-09. Estimated completion is 2014-08.

What conditions does trial NCT01847040 study?

This clinical trial studies the following conditions: Mild Traumatic Brain Injury.

Who is sponsoring clinical trial NCT01847040?

This trial is sponsored by The Defense and Veterans Brain Injury Center, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01847040 being conducted?

This trial has 2 study locations across Colorado, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01847040's enrollment target sits among peer trials

750 3rd of 43 higher than 41 of 43 other Mild Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02048332 · 750 participants · Phase 1

    Donor-Derived Viral Specific T-cells (VSTs)

  • NCT02087852 · 750 participants

    Kidney Cancer DNA Registry

  • NCT02532452 · 750 participants · Phase 2

    Third Party Viral Specific T-cells (VSTs)

  • NCT03126916 · 750 participants · Phase 3

    Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01847040, the US trial registry maintained by the National Library of Medicine. NCT01847040 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.